Inhalation assessment - Gerresheimer

Inhalation assessment

Gerresheimer respimetrix’ inhalation assessment platform provides unique respiratory information for patients, physicians, disease management companies and the pharmaceutical industry.

The platform uses a patented flow sensor to accurately monitor every single inhalation operation. The sensor connects to customary inhalers or can be integrated in future generations of inhalers and assesses every inhalation maneuver and tracks changes of the respiratory behavior of the patient.
 

Respiratory drug delivery is a complex issue with little or no information

Today, pharma, physicians and providers are running almost blind and find it challenging to identify the reasons why patient treatment is not effective. Caregivers don’t know if the patient simply forgot to inhale, does not perform the inhalation properly or if the drug is not effective.

In addition, reliable, daily information about the patient’s health status are missing. Patients may run into frequent exacerbations before their caregivers are realizing that there may be a decline.
 

The Asthma and COPD therapy adherence problem creates uncontained cost and unpredictable outcomes

  • Patient perspective: Worldwide more than 500 million people suffer from Asthma and COPD. Up to 50% fail to use their therapy in the right way resulting in symptom persistence and frequent hospital and office visits.
  • Physician perspective: Therapies are effective only if used as prescribed. Physicians have limited ability to monitor therapy usage and compliance.
  • Payer perspective: Non-adherent patients utilize healthcare services as if they were untreated. 50 billion USD are wasted in the US alone
  • Pharma perspective: Payer pressure forcing new ways to monitor exactly how medicines and devices are working and being used by patients.
     

Gerresheimer respimetrix’ platform provides unique respiratory information for patients, physicians, disease management companies and the pharmaceutical industry

  • Monitoring of device usage
  • Data capture and analysis of each breath during the inhalation maneuver
  • Qualification of the lung health status and tracking over time
  • Reliable feedback to patients and caregivers over Smartphone and Cloud
     

Valuable data from every single breath

Gerresheimer respimetrix’ platform using a patented flow sensor to accurately monitor every single inhalation is ideally suited to assess inhalation maneuvers and to track changes over time.

Robust, high-dynamic measure of breathing airflow

Patient-centric app

Proprietary algorithms analyze the dynamic flow data and interpret them in a clinical context

Disease management today and tomorrow

The platform introduces efficiency and increased quality of care by remotely delivering objective data every-day to the person in charge of managing the patient

Contact us!

Inhalation assessment
Dr. Paul Senn
Managing Director
Phone: +41 62 209 7108
E-Mail: Dr. Paul Senn